alogliptin and metformin hydrochloride
Drug Details
- Generic Name
- alogliptin and metformin hydrochloride
- Brand Names
- alogliptin and metformin hydrochloride, KAZANO
- Application Number
- NDA203414
- Sponsor
- Padagis Israel Pharmaceuticals Ltd
- NDC Codes
- 9
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- ALOGLIPTIN BENZOATE, METFORMIN HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE KAZANO is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. KAZANO is a combination of alogliptin, a dipeptidyl-peptidase-4 (DPP-4) inhibitor and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) Limitations of Use: Should not be used in patients with type 1 diabetes mellitus. ( 1 ) Limitations of Use KAZANO is not recommended for use in patients with type 1 diabetes mellitus.